At first glance, I didn't read it that way. However, when
At first glance, I didn't read it that way. However, when you pointed it out, it became almost obvious. There is a lot here; you're right.
I read that they are doing fine with their old and trusty YAK line and don't feel like competing with YAK by pushing Dharmanol and T-Hydrocan which they say they are still perfecting.
YAK is their product line that pre-dates founding of Berkeley Bio, SK sub. That line is much more exclusively GoldNApel's line than Med Greens, would it not be? The licensing schedule for YAK might be more favorable to GoldNApel and the gross profit greater to GoldNApel. Follow the money?
Another thought. Is there a rift here? When iequity grabbed the IP in the AV matter, did that change any terms in licensing agreement to make it more favorable for GoldNApel to stay focused on their YAK line pursuant to sales?
Another thought. Is this their diplomatic way of saying Dharmanol and T-Hydrocan are not selling well and/or have not been received well so they will stay with YAK?
Finally, it wasn't signed. I wonder who wrote it.
"The new product lines we are developing, Dharmanol™ and T-Hydrocan™, are meant to “upgrade” the YAK capsule model to be more in line with the nutraceutical / pharmaceutical market, as opposed to the more casual approach ... Because we have the YAK Capsules available in hundreds of California dispensaries, we feel that we can take our time somewhat in perfecting our new offerings, because the market for them is being fulfilled with the YAK capsules currently, which generate substantial ongoing revenues, and have done so for about six years."
SK3 Group Inc. (SKTO) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...
Continue Reading
Top 5 Most Recently Viewed Articles
Investing in Boston Scientific: A Decade of Growth Boston Scientific (BSX) has turned in a standout decade. Over the last 10 years, the stock delivered an annualized return of 21.0%, outpacing expectations and rewarding patient shareholders. That kind of consistency doesn’t happen by accident. It reflects a company that’s executed well in a competitive corner of...
Continue Reading
Transforming Small Investments into Significant Returns Over the past five years, GameStop (GME) has made quite an impact, grabbing headlines and changing market dynamics. Investors who believed in GameStop have enjoyed impressive returns, beating the market by 63.2% annually, with an average annual return reaching an astonishing 77.15%. Currently, GameStop boasts a...
Continue Reading
The markets have thrown their fair share of curveballs lately, but UP Fintech seems to be hitting them out of the park. Despite geopolitical shake-ups and the threatening shadow of stagflation, the folks at Ticker: TIGR are delivering some head-turning numbers. They’ve rolled out their unaudited Q1 results showing a solid 26.3% increase in revenue year-over-year,...
Continue Reading
Unity Software's Stock Market Movement: An Overview Unity Software (NYSE: U) recently faced a significant stock decline, with shares dropping nearly 30%, leaving many investors questioning the underlying causes. This decline pushed Unity's stock price around $20.43, a level not seen in years, leading to an apparent misalignment between market sentiment and the company’s...
Continue Reading
North American Construction Group Shareholder Meeting Results North American Construction Group Ltd. (TSX:NOA/NYSE:NOA) recently held its Annual Meeting of Shareholders, and the outcomes reflect strong support for the company's leadership and direction. During this pivotal gathering, shareholders actively participated in key decisions that shape the future of the...
Continue Reading